Latest Blood culture Stories
First Diagnostic Test for Identifying E. coli, K. pneumoniae and P.
Pathogen Identification Results in 90 Minutes Direct from Positive Blood Cultures Faster Results to Help Clinicians Improve Antibiotic Selection and Outcomes for Critical Infections WOBURN, Mass.
First hospital in northern Illinois to use a new, cutting edge diagnostic technology to fight serious infections and improve patient care and outcomes. WOBURN, Mass. and VEDBAEK, Denmark, Feb.
First Diagnostic Test for Identifying E. coli and P. aeruginosa Directly from Positive Blood Cultures PNA FISH to Provide Critical Results 24-48 Hours Sooner Than Conventional Methods Helping Clinicians to Improve Care and Outcomes for 100,000 Patients with Bloodstream Infections WOBURN, Mass.
Finnish biotechnology company Mobidiag launches its first CE-marked product for In Vitro Diagnostics (IVD) of sepsis.
SUNNYVALE, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Cepheid today announced it has received clearance from the U.S.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., today announced that as a result of a Co-Marketing Agreement between C.R.
AACC Annual Meeting - Seegene's Seeplex(R) Sepsis multi-pathogen screening test introduced today at the 2008 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry (AACC) brings a novel and fast-acting diagnostic technique for hospitals to simultaneously verify a complex range of targets that indicate sepsis, the leading cause of death in non-coronary intensive care units worldwide.
WOBURN, Mass., July 15 /PRNewswire/ -- AdvanDx today announced that a new study shows use of AdvanDx's PNA FISH(TM) test was associated with an 82% reduction in mortality rates from S.
The prompt and accurate detection of bacteremia and fungemia is one of the most important functions of clinical microbiology laboratories.
- A volcanic mudflow.